文献速递治疗药物监测与药物基因组学药物不良反应与药物警戒

应用剂量标准优化三环类抗抑郁药药物基因组学临床决策支持

Impact of using dosing criteria to refine pharmacogenomic clinical decision support for tricyclic antidepressants.
PubMed 文献 · Am J Health Syst Pharm · 2025-01-01

本研究评估了剂量特异性逻辑用于三环类抗抑郁药(TCA)药物基因组学(PGx)临床决策支持(CDS)的影响。回顾性图表审查显示,应用剂量标准后TCA警报量减少74.8%,非行为健康专科因非焦虑或抑郁适应症处方导致的警报下降最明显(P=0.035)。结论认为以剂量为中心的警报可作为实现最佳剂量的策略。

要点

  • 剂量标准可减少TCA PGx警报量74.8%,降低警报疲劳。
  • 非行为健康专科因非适应症处方导致的警报下降最显著(P=0.035)。
  • 无剂量标准时,76%的TCA订单用于非抑郁适应症,指南不适用。

核心结论

  • 以剂量为中心的警报可作为实现最佳剂量的策略,在应进行剂量调整时提醒临床医生。

研究设计与样本

  • 回顾性图表审查,比较实施剂量标准前后TCA PGx CDS的警报情况,数据来自电子病历。

主要发现

  • 无剂量标准的队列中,大多数TCA订单用于非抑郁适应症(76%),指南不适用于多数订单。
  • 使用剂量标准优化CDS后,TCA警报量减少74.8%。
  • 非行为健康专科因非焦虑或抑郁适应症处方导致的警报下降最明显(P=0.035)。

临床怎么用

  • 临床可使用剂量特异性逻辑优化TCA PGx CDS,减少不必要警报并促进正确剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the impact of dose-specific logic for tricyclic antidepressant (TCA) pharmacogenomics (PGx) clinical decision support (CDS). We aimed to provide guidance in an area with limited supporting literature, ensure optimal dosing through CDS, and limit alert fatigue. The primary outcome was the reduction in alerts prescribers encountered, while the secondary outcome included an analysis across specialties. METHODS: A retrospective chart review was conducted to examine TCA PGx CDS before and after implementation of dosing criteria for alerts. Data were abstracted from the electronic medical record. A χ2 test was performed to analyze the frequency of alerts in behavioral health and other specialties. RESULTS: In the cohort lacking dose criteria, most TCA orders were for indications other than depression (76%) and guidelines would not apply to the majority of these orders. Using dosing criteria to refine CDS reduced the volume of TCA alerts by 74.8%. Alert volume decreased the most in specialties other than behavioral health due to prescriptions for indications other than anxiety or depression (P = 0.035). CONCLUSION: Dose-centric alerts may be used as a strategy to achieve optimal dosing. Alerting clinicians when dose modifications should occur contributes to getting the right dose to the right patient. Future efforts should focus on optimal dosing of medication through CDS enhancements.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Massmann A, Petry N, Mills S, et al. Impact of using dosing criteria to refine pharmacogenomic clinical decision support for tricyclic antidepressants. Am J Health Syst Pharm. 2025. PMID: 39549283. doi:10.1093/ajhp/zxae337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。